314130 Genome & Co. KRX · South Korea

Genome & Co. (314130) news

Genome & Co. is a public biotech or pharmaceutical company listed on KRX under the ticker 314130, recorded under South Korea. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Genome & Co. news

We have not published a story on Genome & Co. yet. When there is news, it will appear here.

Questions about Genome & Co.

What is the ticker symbol of Genome & Co.?

Genome & Co. trades under the ticker 314130 on KRX.

Where is Genome & Co. listed?

Genome & Co. is listed on KRX.

Which country or territory is Genome & Co. listed under?

Our directory records Genome & Co. under South Korea.

What does Genome & Co. do?

Our directory classifies Genome & Co. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Genome & Co.?

The ISIN recorded for Genome & Co. is KR7314130006.

Does aibio.space cover Genome & Co.?

aibio.space lists Genome & Co. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Genome & Co.?

Companies in our directory listed in the same country and business area as Genome & Co.: Voronoi, Daewon Pharmaceutical Co., GC, Hwail Pharmaceutical Co., Daewoong Co., SK Biopharmaceuticals Co..

Investor discussion: Genome & Co.

Members talk about Genome & Co. (314130). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open KRX:314130 on TradingView.

Listing details

Company: Genome & Co.
Ticker: 314130
Listing: KRX
Country or territory: South Korea
Business scope: Pharmaceuticals: Major
ISIN: KR7314130006
Last quote in directory: 2026-10-22
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction